Skip to content

Laser treatment for acne scars

Evaluating the efficacy of the combination of ablative fractional Er:YAG 2940nm and non-ablative fractional diode 1550nm lasers compered to the ablative fractional Er:YAG 2940nm laser alone in the treatment of atrophic acne scars in patients

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
IRCT
Registry ID
IRCT20240725062539N1
Enrollment
20
Registered
2025-04-30
Start date
2025-04-30
Completion date
Unknown
Last updated
2025-07-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Atrophic acne scars. Scar conditions and fibrosis of skin

Interventions

Intervention 1: First intervention group: laser therapy of scars on one side of the face with ablative fractional Er:YAG 2940nm laser for 4 sessions with monthly intervals. Intervention 2: Second inte

Sponsors

Tehran University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 45 Years

Inclusion criteria

Inclusion criteria: Age 18 to 45 years Atrophic acne scars almost symmetrical on both sides of the face Accepting the study rules and completing the informed consent form Using sunscreen during the treatment and one month after

Exclusion criteria

Exclusion criteria: Having active acne Taking oral isotretinoin in the last 3 months Pregnancy and breastfeeding Peeling, laser, dermabrasion during the last 3 months Taking anticoagulants History of keloid formation Photosensitivity Suffering from diseases that delay wound healing

Design outcomes

Primary

MeasureTime frame
Severity of acne scar based on ECCA scale. Timepoint: At the beginning of the study and one month after the last laser therapy session. Method of measurement: Visio face device, ECCA scale table, Scoring of two dermatologists based on ECCA scale.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactFateme Zahra Talebi

Tehran University of Medical Sciences

razihospital@sina.tums.ac.ir+98 21 5288 8282

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026